15 min listen
An Inside Look at the Role of Data Monitoring Committees with Dr. Jonathan Seltzer
FromWCG Talks Trials
An Inside Look at the Role of Data Monitoring Committees with Dr. Jonathan Seltzer
FromWCG Talks Trials
ratings:
Length:
18 minutes
Released:
Feb 13, 2020
Format:
Podcast episode
Description
In this episode, WCG’s President of Patient Advocacy, Steve Smith, interviews Dr. Jonathan Seltzer, MD, Chief Scientific Officer at WCG, expert on data safety monitoring boards, biomarkers, biostatistics, and clinical endpoints. During their conversation, Steve and Dr. Seltzer discuss how biomarkers are appropriate for the use of trials, especially when clinical data is tough to get. Part of this discussion turns to Duchenne’s Muscular Dystrophy (an inherited rare muscular disease) on how Patient Advocacy Groups are working with the FDA to define risk vs. benefit, and how promising a biomarker for this condition - as well as many other rare disorders - would be.
Released:
Feb 13, 2020
Format:
Podcast episode
Titles in the series (67)
The Most Pressing Challenges in Psychiatry Clinical Trials with Leslie Citrome, MD, MPH by WCG Talks Trials